Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target. - Koni M; Castellano I; Venturelli E; Sarcinella A; Lopatina T; Grange C; Cedrino M; Femminò S; Cossu-Rocca P; Orrù S; D'Ascenzo F; Cotellessa I; et al. (Cancers, 2022)